癌症发生转录因子的最新进展：生物标志物与靶向治疗
Recent Advances in Carcinogenesis Transcription Factors: Biomarkers and Targeted Therapies.
作者信息
Bode Ann M, Zhang Tianshun
机构信息
The Hormel Institute, University of Minnesota, Austin, MN 55912, USA.
出版信息
Cancers (Basel). 2023 Sep 22;15(19):4673. doi: 10.3390/cancers15194673.
Abstract
Carcinogenesis, the process by which normal cells transform into cancer cells, is complex and multifaceted [...].
摘要
致癌作用，即正常细胞转变为癌细胞的过程，是复杂且多方面的[...]。
相似文献
1
Recent Advances in Carcinogenesis Transcription Factors: Biomarkers and Targeted Therapies.癌症发生转录因子的最新进展：生物标志物与靶向治疗
Cancers (Basel). 2023 Sep 22;15(19):4673. doi: 10.3390/cancers15194673.
2
Biomarkers for personalized oncology: recent advances and future challenges.用于肿瘤个体化医学的生物标志物：最新进展与未来挑战。
Metabolism. 2015 Mar;64(3 Suppl 1):S16-21. doi: 10.1016/j.metabol.2014.10.027. Epub 2014 Oct 30.
3
Melatonin and hyperbaric oxygen therapies suppress colorectal carcinogenesis through pleiotropic effects and multifaceted mechanisms.褪黑素和高压氧疗法通过多种作用和多方面的机制抑制结直肠肿瘤的发生。
Int J Biol Sci. 2021 Aug 27;17(14):3728-3744. doi: 10.7150/ijbs.62280. eCollection 2021.
4
Advancements in Zebrafish Models for Breast Cancer Research: Unveiling Biomarkers, Targeted Therapies, and Personalized Medicine.斑马鱼模型在乳腺癌研究中的进展：揭示生物标志物、靶向治疗和个性化医疗。
Med Sci Monit. 2023 Jul 2;29:e940550. doi: 10.12659/MSM.940550.
5
Gastric Cancer: Advances in Carcinogenesis Research and New Therapeutic Strategies.胃癌：癌发生研究进展与新治疗策略
Int J Mol Sci. 2021 Mar 26;22(7):3418. doi: 10.3390/ijms22073418.
6
Recent Advances in Transcription Factors Biomarkers and Targeted Therapies Focusing on Epithelial-Mesenchymal Transition.聚焦上皮-间质转化的转录因子生物标志物与靶向治疗的最新进展
Cancers (Basel). 2023 Jun 25;15(13):3338. doi: 10.3390/cancers15133338.
7
Molecular Mechanisms and Targeted Therapies of Advanced Basal Cell Carcinoma.晚期基底细胞癌的分子机制和靶向治疗。
Int J Mol Sci. 2022 Oct 8;23(19):11968. doi: 10.3390/ijms231911968.
8
Recent advances in understanding breast cancer and emerging therapies with a focus on luminal and triple-negative breast cancer.乳腺癌认识方面的最新进展以及以管腔型和三阴性乳腺癌为重点的新兴疗法。
F1000Res. 2019 Apr 30;8. doi: 10.12688/f1000research.17542.1. eCollection 2019.
9
Spectroscopic evaluation of carcinogenesis in endometrial cancer.光谱学评估子宫内膜癌的癌变。
Sci Rep. 2021 Apr 27;11(1):9079. doi: 10.1038/s41598-021-88640-7.
10
Insight of nitric oxide signaling: A potential biomarker with multifaceted complex mechanism in colorectal carcinogenesis.一氧化氮信号传导的见解：一种在结直肠癌发生中具有多方面复杂机制的潜在生物标志物。
Biochem Biophys Res Commun. 2018 Jan 8;495(2):1766-1768. doi: 10.1016/j.bbrc.2017.12.051. Epub 2017 Dec 9.
本文引用的文献
1
Recent Advances in Transcription Factors Biomarkers and Targeted Therapies Focusing on Epithelial-Mesenchymal Transition.聚焦上皮-间质转化的转录因子生物标志物与靶向治疗的最新进展
Cancers (Basel). 2023 Jun 25;15(13):3338. doi: 10.3390/cancers15133338.
2
SOX1 Functions as a Tumor Suppressor by Repressing HES1 in Lung Cancer.SOX1通过抑制肺癌中的HES1发挥肿瘤抑制作用。
Cancers (Basel). 2023 Apr 8;15(8):2207. doi: 10.3390/cancers15082207.
3
Notch pathway regulates osimertinib drug-tolerant persistence in EGFR-mutated non-small-cell lung cancer.Notch 通路调控 EGFR 突变型非小细胞肺癌中奥希替尼耐药性的持续存在。
Cancer Sci. 2023 Apr;114(4):1635-1650. doi: 10.1111/cas.15674. Epub 2022 Dec 7.
4
Analysis of Primary Cilium Expression and Hedgehog Pathway Activation in Mesothelioma Throws Back Its Complex Biology.间皮瘤中初级纤毛表达及刺猬信号通路激活的分析揭示其复杂生物学特性
Cancers (Basel). 2022 Oct 25;14(21):5216. doi: 10.3390/cancers14215216.
5
Hypoxia and ERα Transcriptional Crosstalk Is Associated with Endocrine Resistance in Breast Cancer.缺氧与雌激素受体α转录串扰与乳腺癌内分泌耐药相关。
Cancers (Basel). 2022 Oct 8;14(19):4934. doi: 10.3390/cancers14194934.
6
Advance of SOX Transcription Factors in Hepatocellular Carcinoma: From Role, Tumor Immune Relevance to Targeted Therapy.SOX转录因子在肝细胞癌中的研究进展：从作用、肿瘤免疫相关性到靶向治疗
Cancers (Basel). 2022 Feb 24;14(5):1165. doi: 10.3390/cancers14051165.
7
Hallmarks of Cancer: New Dimensions.癌症的特征：新视角。
Cancer Discov. 2022 Jan;12(1):31-46. doi: 10.1158/2159-8290.CD-21-1059.
8
Epithelial-mesenchymal transition and its transcription factors.上皮-间充质转化及其转录因子。
Biosci Rep. 2022 Jan 28;42(1). doi: 10.1042/BSR20211754.
9
FOXP3 facilitates the invasion and metastasis of non-small cell lung cancer cells through regulating VEGF, EMT and the Notch1/Hes1 pathway.FOXP3通过调节VEGF、EMT和Notch1/Hes1通路促进非小细胞肺癌细胞的侵袭和转移。
Exp Ther Med. 2021 Sep;22(3):958. doi: 10.3892/etm.2021.10390. Epub 2021 Jul 6.
10
Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy.肿瘤微环境中的免疫细胞：在癌症免疫治疗中的生物学功能和作用。
Cancer Lett. 2020 Feb 1;470:126-133. doi: 10.1016/j.canlet.2019.11.009. Epub 2019 Nov 12.
Zotero 插件